OUR PRODUCTS

MOBILE APPS

GENERAL INFO

REPL

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Replimune Group (REPL) Earnings Date & Reports

Replimune Group Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

REPL is expected to report earnings to fall 22.65% to -73 cents per share on November 18

Replimune Group REPL Stock Earnings Reports

Q3'25

Est.

$-0.73

Q2'25

Missed

by $0.11

Q1'25

Missed

by $2.35

Q4'24

Missed

by $0.03

Q3'24

Beat

by $0.14

The last earnings report on August 07 showed earnings per share of -94 cents, missing the estimate of -84 cents. With 1.36M shares outstanding, the current market capitalization sits at 412.92M.

View a ticker or compare two or three

Compare

REPL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For REPL
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. REPL showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

500 Unicorn Park Drive

Phone

+1 781 222-9600

Employees

284

Web

https://www.replimune.com